The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
An analysis of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer on survival in a pooled analysis of EORTC 22921 and FFCD 9203 trials: Surrogacy in question?
F. Bonnetain
No relevant relationships to disclose
J. Bosset
No relevant relationships to disclose
J. Gerard
No relevant relationships to disclose
G. Calais
No relevant relationships to disclose
T. Conroy
No relevant relationships to disclose
L. Mineur
No relevant relationships to disclose
O. Bouche
No relevant relationships to disclose
P. Maingon
No relevant relationships to disclose
O. Chapet
No relevant relationships to disclose
L. Radosevic-Jelic
No relevant relationships to disclose
N. Methy
No relevant relationships to disclose
L. Collette
No relevant relationships to disclose